S

Samil Pharmaceutical Co Ltd
KRX:000520

Watchlist Manager
Samil Pharmaceutical Co Ltd
KRX:000520
Watchlist
Price: 10 130 KRW -2.41% Market Closed
Market Cap: 219.7B KRW

Net Margin
Samil Pharmaceutical Co Ltd

-9.1%
Current
-2%
Average
4.7%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-9.1%
=
Net Income
-19.8B
/
Revenue
217.2B

Net Margin Across Competitors

No Stocks Found

Samil Pharmaceutical Co Ltd
Glance View

Market Cap
215.1B KRW
Industry
Pharmaceuticals

SAMIL PHARMACEUTICAL Co., Ltd. engages in the development and manufacture of pharmaceutical products. The company is headquartered in Seoul, Seoul. The Company’s products portfolio consists of gastro-intestinal drugs such as antiulcerants, gastroprokinetic agents, digestive enzymes with nutrients and laxatives under the brand names of Plybutine, Gliptide and others; antipyretic, analgesic and anti-inflammatory agents under the brand name Brufen; nutritional supplements such as vitamins, minerals and immunosuppressants, and others including antigout agents, anti-parkinsonism agents and others. In addition, it is engaged in the provision of miscellaneous goods. The firm distributes its products within domestic market and to overseas markets. On November 29, 2013, it transferred its entire shares of a Korea-based company, which is engaged in the sale of medical products.

Samil Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-9.1%
=
Net Income
-19.8B
/
Revenue
217.2B
What is the Net Margin of Samil Pharmaceutical Co Ltd?

Based on Samil Pharmaceutical Co Ltd's most recent financial statements, the company has Net Margin of -9.1%.

Back to Top